Evidence map›Paper›PMID 31511646›Full record

ArticleOncogene2020

Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.

Tingting Yang, Chune Ren, Pengyun Qiao, Xue Han, Li Wang, Shijun Lv, Yonghong Sun, Zhijun Liu, Yu Du, Zhenhai Yu

Open access · hybridAbstract readPublished Erratum
In one paragraph

Article in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 90 citations in OpenAlex.

  1. Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA.International journal of molecular sciences · 2023
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tingting Yang *Department of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, PR China.
Chune Ren *Department of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, PR China.
Pengyun Qiao *Department of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, PR China.
Xue Han *Department of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, PR China.
Li WangDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, PR China.
Shijun LvDepartment of Pathology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, PR China.
Yonghong SunDepartment of Pathology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, PR China.
Zhijun LiuDepartment of Medical Microbiology, Weifang Medical University, Weifang, Shandong, PR China.
Yu DuDepartment of Medical Microbiology, Weifang Medical University, Weifang, Shandong, PR China.
Zhenhai YuDepartment of Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, PR China. tomsyu@163.com.
Weifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A correction to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31511646
PMCPMC7608437
OpenAlexW2839330588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.